Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2021-07-17
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Novel Equation for Estimating Sodium Intake in Peritoneal Dialysis.
NCT05955417
Relating Abdominal Complications With Peritoneal Pressure Estimation and Reporting
NCT06060951
The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease
NCT06841224
Intra-abdominal Pressure in Peritoneal Dialysis Patients
NCT02811640
ADPKD and Peritoneal Dialysis: How Anticipate Peritoneal Pressure?
NCT03970018
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dialysis length \>1 month
* Aged 18-80 years
* Injection volume of peritoneal dialysis solution\>1500ml
Exclusion Criteria
* History of abdominal surgery and trauma 1 month prior to the study
* Previous history of hernia, leakage, or thoracoabdominal fistula
* Can't come for a follow-up visit
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University First Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong Jie
Clinical Professor in Renal Division, Department of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jie Dong
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IPP equation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.